Long non-coding RNA LINC01270 is an onco-promotor in lung adenocarcinoma by upregulating LARP1 via sponging miR-326

References

• Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007;450(7171):893–898.
   PubMed Web of Science ®Google Scholar
• McErlean A, Ginsberg MS. Epidemiology of lung cancer. Semin Roentgenol. 2011;46(3):173–177.
   PubMed Web of Science ®Google Scholar
• Zhou M, Guo M, He D, et al. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer. J Transl Med. 2015;13(1):231.
   PubMedGoogle Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47–62.
   PubMed Web of Science ®Google Scholar
• Chu C, Qu K, Zhong FL, et al. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell. 2011;44(4):667–678.
   PubMed Web of Science ®Google Scholar
• Hung T, Chang HY. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol. 2010;7(5):582–585.
   PubMed Web of Science ®Google Scholar
• Claverie JM. Fewer genes, more noncoding RNA. Science. 2005;309(5740):1529–1530.
   PubMed Web of Science ®Google Scholar
• Chen W, Bocker W, Brosius J, et al. Expression of neural BC200 RNA in human tumours. J Pathol. 1997;183(3):345–351.
   PubMed Web of Science ®Google Scholar
• Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol. 2012;29(6):613–624.
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834–838.
   PubMed Web of Science ®Google Scholar
• Benhamou D, Labi V, Novak R, et al. A c-Myc/miR17-92/Pten axis controls PI3K-Mediated positive and negative selection in B cell development and reconstitutes CD19 deficiency. Cell Rep. 2016;16(2):419–431.
   PubMed Web of Science ®Google Scholar
• Hong CC, Chen PS, Chiou J, et al. miR326 maturation is crucial for VEGF-C-driven cortactin expression and esophageal cancer progression. Cancer Res. 2014;74(21):6280–6290.
   PubMed Web of Science ®Google Scholar
• Ji S, Zhang B, Kong Y, et al. miR-326 inhibits gastric cancer cell growth through downregulating NOB1. Oncol Res. 2017;25(6):853–861.
   PubMed Web of Science ®Google Scholar
• Sun C, Huang C, Li S, et al. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development. Oncotarget. 2016;7(7):8341–8359.
   PubMedGoogle Scholar
• Li D, Du X, Liu A, et al. Suppression of nucleosome-binding protein 1 by miR-326 impedes cell proliferation and invasion in non-small cell lung cancer cells. Oncol Rep. 2016;35(2):1117–1124.
   PubMed Web of Science ®Google Scholar
• Kefas B, Comeau L, Floyd DH, et al. The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J Neurosci. 2009;29(48):15161–15168.
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu H, Xia J, et al. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol. 2010;79(6):817–824.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang T, Guo R, et al. Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1. J Drug Target. 2015;23(6):519–524.
   PubMed Web of Science ®Google Scholar
• Burrows C, Abd Latip N, Lam SJ, et al. The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration. Nucleic Acids Res. 2010;38(16):5542–5553.
   PubMed Web of Science ®Google Scholar
• Xie C, Huang L, Xie S, et al. LARP1 predict the prognosis for early-stage and AFP-normal hepatocellular carcinoma. J Transl Med. 2013;11(1):272.
   PubMedGoogle Scholar
• Hudson ME, Pozdnyakova I, Haines K, et al. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci U S A. 2007;104(44):17494–17499.
   PubMed Web of Science ®Google Scholar
• Hopkins TG, Mura M, Al-Ashtal HA, et al. The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer. Nucleic Acids Res. 2016;44(3):1227–1246.
   PubMed Web of Science ®Google Scholar
• Xu Z, Xu J, Lu H, et al. LARP1 is regulated by the XIST/miR-374a axis and functions as an oncogene in non-small cell lung carcinoma. Oncol Rep. 2017;38(6):3659–3667.
   PubMed Web of Science ®Google Scholar
• Han J, Zhao G, Ma X, et al. CircRNA circ-BANP-mediated miR-503/LARP1 signaling contributes to lung cancer progression. Biochem Biophys Res Commun. 2018;503(4):2429–2435.
   PubMed Web of Science ®Google Scholar
• Mura M, Hopkins TG, Michael T, et al. LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression. Oncogene. 2015;34(39):5025–5036.
   PubMed Web of Science ®Google Scholar
• Li G, Liu K, Du X. Long Non-Coding RNA TUG1 promotes proliferation and inhibits apoptosis of osteosarcoma cells by sponging miR-132-3p and upregulating SOX4 expression. Yonsei Med J. 2018;59(2):226–235.
   PubMed Web of Science ®Google Scholar
• Wang ZY, Hu M, Dai MH, et al. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/beta-catenin signaling pathway. Mol Cancer. 2018;17(1):3.
   PubMedGoogle Scholar
• Wang SH, Yang Y, Wu XC, et al. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression. Cancer Lett. 2016;380(1):122–133.
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhao X, Liu Q, et al. lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/beta-catenin signaling. Nat Med. 2017;23(11):1331–1341.
   PubMed Web of Science ®Google Scholar
• Liu X, Liang Y, Song R, et al. Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation. Mol Cancer. 2018;17(1):90.
   PubMedGoogle Scholar
• Sun LY, Li XJ, Sun YM, et al. LncRNA ANRIL regulates AML development through modulating the glucose metabolism pathway of AdipoR1/AMPK/SIRT1. Mol Cancer. 2018;17(1):127.
   PubMedGoogle Scholar
• Xiao ZD, Han L, Lee H, et al. Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development. Nat Commun. 2017;8(1):783.
   PubMedGoogle Scholar
• Li D, Liu X, Zhou J, et al. Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis. Hepatology. 2017;65(5):1612–1627.
   PubMed Web of Science ®Google Scholar
• Huang H, Yang C, Zhang Q, et al. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression. Bioengineered. 2022;13(3):4964–4977.
   PubMed Web of Science ®Google Scholar
• Wang Y, Fu J, Wang Z, et al. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis. Cancer Biomark. 2019;25(4):313–324.
   PubMed Web of Science ®Google Scholar
• Li N, Zhao Z, Miao F, et al. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation. Cancer Gene Ther. 2021;28(5):471–485.
   PubMed Web of Science ®Google Scholar
• Ping J, Huang S, Wu J, et al. Association between lincRNA expression and overall survival for patients with triple-negative breast cancer. Breast Cancer Res Treat. 2021;186(3):769–777.
   PubMed Web of Science ®Google Scholar
• Martini M, De Santis MC, Braccini L, et al. PI3K/AKT signaling pathway and cancer: an updated review, Ann. Med. 2014;46(6):372–383.
   Web of Science ®Google Scholar
• Roessler K, Dietrich W, Kitz K. Expression of BCL-2 oncoprotein on tumor cells and tumor-infiltrating lymphocytes (TIL) in meningiomas. Neurosurg Rev. 1999;22(4):205–209.
   PubMed Web of Science ®Google Scholar
• Chen J, Li X, Cheng Q, et al. Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells. J Cell Biochem. 2017;119(2):2368–2380.
   PubMed Web of Science ®Google Scholar
• Dong HX, Wang R, Jin XY, et al. LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p. J Cell Physiol. 2018;233(5):4126–4136.
   PubMed Web of Science ®Google Scholar
• Zhang L, Huang P, Li Q, et al. miR-134-5p promotes stage I lung adenocarcinoma metastasis and chemoresistance by targeting DAB2. Mol Ther Nucleic Acids. 2019;18:627–637.
   PubMedGoogle Scholar
• Wan S, Liu Z, Chen Y, et al. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase). Bioengineered. 2021;12(2):11959–11977.
   PubMed Web of Science ®Google Scholar
• Li J, Li S, Chen Z, et al. miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1. Tumour Biol. 2016;37(10):13287–13294.
   PubMedGoogle Scholar
• Xia Z, Zheng X, Zheng H, et al. Cold-inducible RNA-binding protein (CIRP) regulates target mRNA stabilization in the mouse testis. FEBS Lett. 2012;586(19):3299–3308.
   PubMed Web of Science ®Google Scholar
• Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins. Nat Rev Genet. 2014;15(12):829–845.
   PubMed Web of Science ®Google Scholar
• Ye L, Lin ST, Mi YS, et al. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target. Tumour Biol. 2016;37(11):14585–14594.
   PubMedGoogle Scholar